Biosynthesis of glycolipid precursors for glycosylphosphatidylinositol membrane anchors in a Toxoplasma gondii cell-free system.
Toxoplasmosis, a disease that affects humans and a wide variety of mammals is caused by Toxoplasma gondii, the obligate intracellular coccidian protozoan parasite. Most T. gondii research has focused on the rapidly growing invasive form, the tachyzoite, which expresses five major surface proteins attached to the parasite membrane by glycosylphosphatidylinositol (GPI) anchors. We have recently reported the purification and partial characterization of candidate precursor glycolipids (GPIs) from metabolically labeled parasites and have presented evidence that these GPIs have a linear glycan backbone sequence indistinguishable from the GPI core glycan of the major tachyzoite surface protein, P30. In this report, we describe a cell-free system derived from tachyzoite membranes which is capable of catalyzing GPI biosynthesis. Incubation of the membrane preparations with radioactive sugar nucleotides (GDP-[3H]mannose or UDP-[3H]GlcNAc) resulted in incorporation of radiolabeled into numerous glycolipids. By using a combination of chemical/enzymatic tests and chromatographic analysis, a series of incompletely glycosylated lipid species and mature GPIs have been identified. We have also established the involvement of Dol-P-mannose in the synthesis of T. gondii GPIs by demonstrating that the incorporation of [3H]mannose into the mannosylated GPIs is stimulated by dolichylphosphate and inhibited by amphomycin. In addition, increasing the concentration of nonradioactive GDP mannose resulted in a loss of radiolabel from the first easily detectable GPI precursor, GlcN-PI, and a concomittant appearance of the radio-activity into mannosylated glycolipids. Altogether, our data suggest that the GPI core glycan in T. gondii is assembled via sequential glycosylation of phosphatidylinositol, as proposed for the biosynthesis of GPIs in Trypanosoma brucei. In contrast to T. brucei, preliminary experiments indicate that the core glycan of some GPIs synthesized by the T. gondii cell-free system is modified by N-acetylgalactosamine similar to the situation for mammalian Thy-1.
Tomavo
S
S
Medizinische Zentrum für Hygiene and Medizinische Mikrobiologie, Philipps Universität Marburg, Germany.
Dubremetz
J F
JF
Schwarz
R T
RT
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002240:Carbohydrate Sequence; D002474:Cell-Free System; D002852:Chromatography, Ion Exchange; D002855:Chromatography, Thin Layer; D003065:Coenzyme A / Q000378:metabolism; D004288:Dolichol Phosphates / Q000494:pharmacology; D006017:Glycolipids / Q000096:biosynthesis*; D017261:Glycosylphosphatidylinositols / Q000378:metabolism*; D006868:Hydrolysis; D055666:Lipopeptides; D008358:Mannose / Q000378:metabolism; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000494:pharmacology; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D014122:Toxoplasma / Q000378:metabolism*
D004288:Dolichol Phosphates; D006017:Glycolipids; D017261:Glycosylphosphatidylinositols; D055666:Lipopeptides; D009842:Oligopeptides; C004423:amphomycin; D000255:Adenosine Triphosphate; D010727:Phosphoric Diester Hydrolases; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D008358:Mannose; D003065:Coenzyme A